New iVillage site offers ‘Dr. Mom' tools

Share this article:
NBC Universal's iVillage Properties has launched a new consumer online health destination targeting women and their families.

The Web site called iVillage Total Health can be found at www.health.ivillage.com.

“We plan to work with a number of pharmaceutical companies and offer a wide range of marketing opportunities from traditional display to direct marketing to custom solutions,” Jane Lehman, an iVillage spokeswoman, told MM&M.

Companies already on board include Pfizer and AstraZeneca.

The site aims to offer “‘Dr. Mom' the health information and tools she needs to best manage her family's healthcare,” said Deborah Fine, president of iVillage Properties, in a statement.

The site offers info on medical research and developments, personalized tools such as a “Symptom Solver” and “Healthy Living” diet program.

Lehman said that the iVillage Total Health site will continue to evolve during the coming months with new features.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...